Literature DB >> 30859284

Epicardial fat volume measured on nongated chest CT is a predictor of coronary artery disease.

Yasunori Nagayama1, Naoki Nakamura2, Ryo Itatani2, Seitaro Oda3, Shinichiro Kusunoki2, Hideo Takahashi2, Takeshi Nakaura3, Daisuke Utsunomiya4, Yasuyuki Yamashita3.   

Abstract

OBJECTIVE: To investigate whether epicardial fat volume (EFV) quantified on ECG-nongated noncontrast CT (nongated-NCCT) could be used as a reliable and reproducible predictor for coronary artery disease (CAD).
METHODS: One hundred seventeen subjects (65 men, mean age 66.6 ± 11.9 years) underwent coronary CT angiography (CCTA) and nongated-NCCT during a single session because of symptoms suggestive of CAD. Two observers independently quantified EFV on both images. Correlation between CCTA-EFV and nongated-NCCT-EFV was assessed using Pearson's correlation coefficient and Bland-Altman plots. Inter-observer agreement was analyzed using concordance correlation coefficients (CCC). Coronary risk factors including EFV were compared between CAD-positive (> 50% stenosis) and CAD-negative groups. The association between EFV and CAD was analyzed using multivariate logistic regression. ROC analysis was performed, and AUC was compared with DeLong's method.
RESULTS: Seventy-four subjects were diagnosed with CAD. An excellent correlation was noted between CCTA-EFV and nongated-NCCT-EFV (r = 0.948, p < 0.001), despite the systematic difference between both measurements (mean bias, 1.26). Inter-observer agreement was nearly perfect (CCC, 0.988 and 0.985 for CCTA and nongated-NCCT, respectively, p < 0.001). Significant differences were noted between subjects with versus without CAD in age, hypertension, and EFV on both types of images (p ≤ 0.026). Multivariate analysis revealed that increased EFV on CCTA (odds ratio 1.185, p = 0.003) and nongated-NCCT (odds ratio 1.20, p = 0.015) was independently associated with CAD. There was no significant difference between CCTA-EFV and nongated-NCCT-EFV in AUC for the prediction of CAD (0.659 vs 0.665, p = 0.706).
CONCLUSIONS: Despite the absence of ECG gating, EFV measured on NCCT may serve as a reproducible predictor for CAD with accuracy equivalent to EFV measured on CCTA. KEY POINTS: • Despite the absence of ECG gating, the EFV on NCCT provides nearly perfect inter-observer reproducibility and shows excellent correlation with measurements on gated CCTA. • EFV on nongated-NCCT may serve as an independent biomarker for predicting coronary artery disease with accuracy equivalent to that of EFV on gated CCTA.

Entities:  

Keywords:  Body fat distribution; Coronary artery disease; Multidetector computed tomography; Pericardium; Predictive value of tests

Mesh:

Year:  2019        PMID: 30859284     DOI: 10.1007/s00330-019-06079-x

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  37 in total

Review 1.  Measuring agreement in method comparison studies.

Authors:  J M Bland; D G Altman
Journal:  Stat Methods Med Res       Date:  1999-06       Impact factor: 3.021

Review 2.  Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart.

Authors:  Gianluca Iacobellis; Domenico Corradi; Arya M Sharma
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2005-10

3.  Reproducibility of echocardiographic measurements of epicardial fat thickness.

Authors:  Daniel Saura; María J Oliva; Daniel Rodríguez; Domingo A Pascual-Figal; Jose A Hurtado; Eduardo Pinar; Gonzalo de la Morena; Mariano Valdés
Journal:  Int J Cardiol       Date:  2008-12-24       Impact factor: 4.164

4.  Is the epicardial adipose tissue area on non-ECG gated low-dose chest CT useful for predicting coronary atherosclerosis in an asymptomatic population considered for lung cancer screening?

Authors:  Kyu-Chong Lee; Hwan Seok Yong; Jaewook Lee; Eun-Young Kang; Jin Oh Na
Journal:  Eur Radiol       Date:  2018-06-28       Impact factor: 5.315

Review 5.  2016 SCCT/STR guidelines for coronary artery calcium scoring of noncontrast noncardiac chest CT scans: A report of the Society of Cardiovascular Computed Tomography and Society of Thoracic Radiology.

Authors:  Harvey S Hecht; Paul Cronin; Michael J Blaha; Matthew J Budoff; Ella A Kazerooni; Jagat Narula; David Yankelevitz; Suhny Abbara
Journal:  J Cardiovasc Comput Tomogr       Date:  2016-11-10

Review 6.  Quantification of epicardial fat by computed tomography: why, when and how?

Authors:  Mohamed Marwan; Stephan Achenbach
Journal:  J Cardiovasc Comput Tomogr       Date:  2013-01-19

7.  Liver fat is related to cardiovascular risk factors and subclinical vascular disease: the Rotterdam Study.

Authors:  Lennard Wolff; Daniel Bos; Sarwa Darwish Murad; Oscar H Franco; Gabriel P Krestin; Albert Hofman; Meike W Vernooij; Aad van der Lugt
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2016-08-22       Impact factor: 6.875

8.  Epicardial adipose tissue volume assessed by computed tomography and coronary artery disease: a systematic review and meta-analysis.

Authors:  Jennifer Mancio; Diana Azevedo; Francisca Saraiva; Ana Isabel Azevedo; Gustavo Pires-Morais; Adelino Leite-Moreira; Ines Falcao-Pires; Nuno Lunet; Nuno Bettencourt
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2018-05-01       Impact factor: 6.875

9.  Diameter of the Pulmonary Artery in Relation to the Ascending Aorta: Association with Cardiovascular Outcome.

Authors:  Andreas A Kammerlander; Stefan Aschauer; Caroline Zotter-Tufaro; Franz Duca; Klaus Knechtelsdorfer; Matthias Wiesinger; Marianne L Schwaiger; Daniel Dalos; Matthias Schneider; Beatrice A Marzluf; Diana Bonderman; Julia Mascherbauer
Journal:  Radiology       Date:  2017-05-29       Impact factor: 11.105

10.  Quantification of epicardial and peri-coronary fat using cardiac computed tomography; reproducibility and relation with obesity and metabolic syndrome in patients suspected of coronary artery disease.

Authors:  Petra M Gorter; Anne S R van Lindert; Alexander M de Vos; Matthijs F L Meijs; Yolanda van der Graaf; Pieter A Doevendans; Mathias Prokop; Frank L J Visseren
Journal:  Atherosclerosis       Date:  2007-09-19       Impact factor: 5.162

View more
  6 in total

1.  Measurement of epicardial adipose tissue using non-contrast routine chest-CT: a consideration of threshold adjustment for fatty attenuation.

Authors:  Lekang Yin; Cheng Yan; Chun Yang; Hao Dong; Shijie Xu; Chenwei Li; Mengsu Zeng
Journal:  BMC Med Imaging       Date:  2022-06-25       Impact factor: 2.795

Review 2.  Novel imaging biomarkers: epicardial adipose tissue evaluation.

Authors:  Caterina B Monti; Marina Codari; Carlo Nicola De Cecco; Francesco Secchi; Francesco Sardanelli; Arthur E Stillman
Journal:  Br J Radiol       Date:  2019-12-11       Impact factor: 3.039

3.  The relationship between quantitative epicardial adipose tissue based on CT and coronary artery disease: A protocol for systematic review and meta-analysis.

Authors:  Baohua Wu; Zhuanqin Ren; Zhengang Du; Lei Zhang; Bin Hou
Journal:  Medicine (Baltimore)       Date:  2020-12-18       Impact factor: 1.817

Review 4.  Role of anatomical location, cellular phenotype and perfusion of adipose tissue in intermediary metabolism: A narrative review.

Authors:  Stefania Camastra; Ele Ferrannini
Journal:  Rev Endocr Metab Disord       Date:  2022-01-15       Impact factor: 6.514

5.  Association of epicardial adipose tissue with different stages of coronary artery disease: A cross-sectional UK Biobank cardiovascular magnetic resonance imaging substudy.

Authors:  Anne Ruth van Meijeren; Daan Ties; Marie-Sophie L Y de Koning; Randy van Dijk; Irene V van Blokland; Pablo Lizana Veloz; Gijs van Woerden; Rozemarijn Vliegenthart; Gabija Pundziute; Daan B Westenbrink; Pim van der Harst
Journal:  Int J Cardiol Heart Vasc       Date:  2022-03-29

Review 6.  Epicardial Adipose Tissue: A Novel Potential Imaging Marker of Comorbidities Caused by Chronic Inflammation.

Authors:  Maria Grazia Tarsitano; Carla Pandozzi; Giuseppe Muscogiuri; Sandro Sironi; Arturo Pujia; Andrea Lenzi; Elisa Giannetta
Journal:  Nutrients       Date:  2022-07-17       Impact factor: 6.706

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.